Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2017

10.11.2016 | Gynecologic Oncology

The impact of inguinal lymph node micrometastases in patients with vulvar cancer

verfasst von: Grigoris Derdelis, Vasilios Pergialiotis, Emmanouil Terzakis, Nektarios Koufopoulos, Ioanna Martzoukou, Chara Gakiopoulou, Andreas Lazaris, Efstratios Patsouris

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Inguinofemoral metastases are a major determinant of vulvar cancer relapse. Until today, the impact of micrometastases of inguinal nodes on local recurrence rates of patients with vulvar cancer remains unknown. The purpose of this retrospective study is to evaluate the rates of micrometastases in a series of patients with vulvar cancer treated with radical vulvectomy and inguinofemoral LND and to assess the probability of cancer relapse among this specific category.

Methods

We conducted a retrospective observational study on patients with vulvar cancer who attended the gynaecological department of Anticancer Hospital of St. Savvas between January 1989 and January 2007. Ultra-staging of lymph nodes for micrometastases was performed after cutting the remaining specimens with a microtome in multiple slices of 3 μm. Subsequently they were stained with traditional hematoxylin and eosin and CK AE1/AE3 antibodies for immunohistochemichal analysis.

Results

Ninety-two patients with primary vulvar malignancies were included in the present retrospective study. Ultrastaging of the lymph nodes revealed micrometastases in five patients (5.4%). Neither the duration of the procedure, nor the number of retrieved lymph nodes was directly associated with the presence of micrometastases. The patients were followed up for more than 5 years. Sixteen recurrences (17.4%) occurred during this period. The presence of micrometastases did not influence the recurrence rate (OR 3.57, 95% CI 0.55–23.36, p = 0.184).

Conclusion

Ultrastaging of inguinal nodes does not seem to add any benefit in the prediction of local recurrence rates. Future multicenter studies are needed in the field to corroborate our findings.
Literatur
2.
Zurück zum Zitat Matthey-Gie ML, Gie O, Deretti S, Demartines N, Matter M (2015) Prospective randomized study to compare lymphocele and lymphorrhea control following inguinal and axillary therapeutic lymph node dissection with or without the use of an ultrasonic scalpel. Ann Surg Oncol. doi:10.1245/s10434-015-5025-y PubMed Matthey-Gie ML, Gie O, Deretti S, Demartines N, Matter M (2015) Prospective randomized study to compare lymphocele and lymphorrhea control following inguinal and axillary therapeutic lymph node dissection with or without the use of an ultrasonic scalpel. Ann Surg Oncol. doi:10.​1245/​s10434-015-5025-y PubMed
3.
Zurück zum Zitat Weldrick C, Bashar K, O’Sullivan TA, Gillis E, Clarke Moloney M, Tang TY, Walsh SR (2014) A comparison of fibrin sealant versus standard closure in the reduction of postoperative morbidity after groin dissection: a systematic review and meta-analysis. Eur J Surg Oncol 40:1391–1398. doi:10.1016/j.ejso.2014.07.034 CrossRefPubMed Weldrick C, Bashar K, O’Sullivan TA, Gillis E, Clarke Moloney M, Tang TY, Walsh SR (2014) A comparison of fibrin sealant versus standard closure in the reduction of postoperative morbidity after groin dissection: a systematic review and meta-analysis. Eur J Surg Oncol 40:1391–1398. doi:10.​1016/​j.​ejso.​2014.​07.​034 CrossRefPubMed
4.
Zurück zum Zitat Torne A, Puig-Tintore LM (2004) The use of sentinel lymph nodes in gynaecological malignancies. Curr Opin Obstet Gynecol 16:57–64CrossRefPubMed Torne A, Puig-Tintore LM (2004) The use of sentinel lymph nodes in gynaecological malignancies. Curr Opin Obstet Gynecol 16:57–64CrossRefPubMed
5.
Zurück zum Zitat Robison K, Steinhoff MM, Granai CO, Brard L, Gajewski W, Moore RG (2006) Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol Oncol 101:24–27. doi:10.1016/j.ygyno.2005.08.052 CrossRefPubMed Robison K, Steinhoff MM, Granai CO, Brard L, Gajewski W, Moore RG (2006) Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol Oncol 101:24–27. doi:10.​1016/​j.​ygyno.​2005.​08.​052 CrossRefPubMed
8.
Zurück zum Zitat Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104CrossRefPubMed Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104CrossRefPubMed
9.
Zurück zum Zitat Tamussino KF, Bader AA, Lax SF, Aigner RM, Winter R (2002) Groin recurrence after micrometastasis in a sentinel lymph node in a patient with vulvar cancer. Gynecol Oncol 86:99–101CrossRefPubMed Tamussino KF, Bader AA, Lax SF, Aigner RM, Winter R (2002) Groin recurrence after micrometastasis in a sentinel lymph node in a patient with vulvar cancer. Gynecol Oncol 86:99–101CrossRefPubMed
10.
Zurück zum Zitat Lawrie TA, Patel A, Martin-Hirsch PP, Bryant A, Ratnavelu ND, Naik R, Ralte A (2014) Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. Cochrane Database Syst Rev 6:CD010409. doi:10.1002/14651858.CD010409.pub2 Lawrie TA, Patel A, Martin-Hirsch PP, Bryant A, Ratnavelu ND, Naik R, Ralte A (2014) Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. Cochrane Database Syst Rev 6:CD010409. doi:10.​1002/​14651858.​CD010409.​pub2
11.
12.
Zurück zum Zitat Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG (1983) Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61:408–412PubMed Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG (1983) Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61:408–412PubMed
13.
Zurück zum Zitat van Beekhuizen HJ, Auzin M, van den Einden LC, de Hullu JA, van der Velden J, Wildhagen MF, van Doorn HC (2014) Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. Int J Gynecol Cancer 24:773–778. doi:10.1097/igc.0000000000000125 CrossRefPubMed van Beekhuizen HJ, Auzin M, van den Einden LC, de Hullu JA, van der Velden J, Wildhagen MF, van Doorn HC (2014) Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. Int J Gynecol Cancer 24:773–778. doi:10.​1097/​igc.​0000000000000125​ CrossRefPubMed
14.
Zurück zum Zitat Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM Jr, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ 2nd, Van Le L, Trimble CL (2012) Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 30:3786–3791. doi:10.1200/jco.2011.41.2528 CrossRefPubMedPubMedCentral Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM Jr, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ 2nd, Van Le L, Trimble CL (2012) Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 30:3786–3791. doi:10.​1200/​jco.​2011.​41.​2528 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, van der Velden J, Hermans RH, van der Putten HW, Drouin P, Runnebaum IB, Sluiter WJ, van der Zee AG (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11:646–652. doi:10.1016/s1470-2045(10)70104-2 CrossRefPubMed Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, van Dorst EB, van der Velden J, Hermans RH, van der Putten HW, Drouin P, Runnebaum IB, Sluiter WJ, van der Zee AG (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11:646–652. doi:10.​1016/​s1470-2045(10)70104-2 CrossRefPubMed
16.
Metadaten
Titel
The impact of inguinal lymph node micrometastases in patients with vulvar cancer
verfasst von
Grigoris Derdelis
Vasilios Pergialiotis
Emmanouil Terzakis
Nektarios Koufopoulos
Ioanna Martzoukou
Chara Gakiopoulou
Andreas Lazaris
Efstratios Patsouris
Publikationsdatum
10.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4233-4

Weitere Artikel der Ausgabe 2/2017

Archives of Gynecology and Obstetrics 2/2017 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.